D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 147 Citations 84,883 316 World Ranking 31 National Ranking 22
Medicine D-index 150 Citations 93,623 354 World Ranking 434 National Ranking 265

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Cancer

Nicholas P. Restifo spends much of his time researching Immunology, Cytotoxic T cell, Antigen, Immunotherapy and T cell. His work deals with themes such as Cancer and Cancer research, Melanoma, which intersect with Immunology. His studies deal with areas such as Molecular biology, CD8 and Cytokine as well as Cytotoxic T cell.

His Antigen research includes elements of Antibody and Virology. His work on Cancer immunotherapy and Cancer vaccine as part of general Immunotherapy study is frequently linked to Natural selection, therefore connecting diverse disciplines of science. Nicholas P. Restifo combines subjects such as Interleukin 2 and Dendritic cell with his study of T cell.

His most cited work include:

  • Cancer immunotherapy: moving beyond current vaccines. (2543 citations)
  • Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (2452 citations)
  • Cancer regression in patients after transfer of genetically engineered lymphocytes (2174 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Immunology, Immunotherapy, T cell, Cytotoxic T cell and Antigen. Nicholas P. Restifo interconnects Cancer research and Melanoma in the investigation of issues within Immunology. His Cancer research study combines topics in areas such as Interleukin 12 and Cytokine.

His Immunotherapy research is multidisciplinary, relying on both Interleukin 2 and Oncology. In his study, Cellular differentiation is strongly linked to Cell biology, which falls under the umbrella field of T cell. His biological study spans a wide range of topics, including Molecular biology and Virology.

He most often published in these fields:

  • Immunology (56.89%)
  • Immunotherapy (32.00%)
  • T cell (30.89%)

What were the highlights of his more recent work (between 2014-2021)?

  • T cell (30.89%)
  • Cancer research (28.67%)
  • Immunotherapy (32.00%)

In recent papers he was focusing on the following fields of study:

Nicholas P. Restifo mainly focuses on T cell, Cancer research, Immunotherapy, Immunology and Adoptive cell transfer. The study incorporates disciplines such as Cell biology, Effector, CD8 and Cytokine in addition to T cell. His CD8 research is multidisciplinary, incorporating perspectives in Cytotoxic T cell and Tyrosine kinase.

The concepts of his Immunotherapy study are interwoven with issues in Melanoma, Oncology and Antigen. The Immunology study combines topics in areas such as Reprogramming and Disease. He has researched Adoptive cell transfer in several fields, including Antibody, Tumor-infiltrating lymphocytes, Cell therapy and Interleukin 15.

Between 2014 and 2021, his most popular works were:

  • Adoptive cell transfer as personalized immunotherapy for human cancer. (1238 citations)
  • A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response (412 citations)
  • Identification of essential genes for cancer immunotherapy (370 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Cancer

His scientific interests lie mostly in Immunotherapy, Immunology, T cell, Cancer research and Adoptive cell transfer. Immunology is closely attributed to Cancer in his work. Nicholas P. Restifo has included themes like Epigenetics, CD8 and Cell biology in his T cell study.

He combines subjects such as Tumor microenvironment, Cytotoxic T cell and Chromatin with his study of CD8. His Cancer research research is multidisciplinary, incorporating elements of Effector, Cancer immunotherapy and T-cell receptor. His biological study spans a wide range of topics, including Oncology, Antigen, Internal medicine, Melanoma and Gene.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cancer immunotherapy: moving beyond current vaccines.

Steven A Rosenberg;James C Yang;Nicholas P Restifo.
Nature Medicine (2004)

3230 Citations

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

Mark E. Dudley;John R. Wunderlich;Paul F. Robbins;James C. Yang.
Science (2002)

3186 Citations

Cancer regression in patients after transfer of genetically engineered lymphocytes

Richard A. Morgan;Mark E. Dudley;John R. Wunderlich;Marybeth S. Hughes.
Science (2006)

3074 Citations

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Steven A. Rosenberg;James C. Yang;Douglas J. Schwartzentruber;Patrick Hwu.
Nature Medicine (1998)

2125 Citations

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Mark E. Dudley;John R. Wunderlich;James C. Yang;Richard M. Sherry.
Journal of Clinical Oncology (2005)

1781 Citations

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy

Steven A. Rosenberg;James C. Yang;Richard M. Sherry;Udai S. Kammula.
Clinical Cancer Research (2011)

1760 Citations

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Giao Q. Phan;James C. Yang;Richard M. Sherry;Patrick Hwu.
Proceedings of the National Academy of Sciences of the United States of America (2003)

1680 Citations

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Steven A. Rosenberg;Nicholas P. Restifo;James C. Yang;Richard A. Morgan.
Nature Reviews Cancer (2008)

1584 Citations

Adoptive immunotherapy for cancer: harnessing the T cell response

Nicholas P. Restifo;Mark E. Dudley;Steven A. Rosenberg.
Nature Reviews Immunology (2012)

1481 Citations

Adoptive immunotherapy for cancer: building on success

Luca Gattinoni;Daniel J. Powell;Steven A. Rosenberg;Nicholas P. Restifo.
Nature Reviews Immunology (2006)

1463 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Nicholas P. Restifo

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 305

Jedd D. Wolchok

Jedd D. Wolchok

Memorial Sloan Kettering Cancer Center

Publications: 199

Francesco M. Marincola

Francesco M. Marincola

National Institutes of Health

Publications: 176

Carl H. June

Carl H. June

University of Pennsylvania

Publications: 165

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 135

Antoni Ribas

Antoni Ribas

University of California, Los Angeles

Publications: 134

Phillip K. Darcy

Phillip K. Darcy

Peter MacCallum Cancer Centre

Publications: 117

Daniel E. Speiser

Daniel E. Speiser

University of Lausanne

Publications: 117

Stanley R. Riddell

Stanley R. Riddell

Fred Hutchinson Cancer Research Center

Publications: 114

George Coukos

George Coukos

University of Lausanne

Publications: 112

Gianpietro Dotti

Gianpietro Dotti

University of North Carolina at Chapel Hill

Publications: 111

Michael H. Kershaw

Michael H. Kershaw

Peter MacCallum Cancer Centre

Publications: 110

Ena Wang

Ena Wang

Nurix Therapeutics

Publications: 106

Patrick Hwu

Patrick Hwu

The University of Texas MD Anderson Cancer Center

Publications: 106

Malcolm K. Brenner

Malcolm K. Brenner

Baylor College of Medicine

Publications: 105

Paul F. Robbins

Paul F. Robbins

National Institutes of Health

Publications: 103

Trending Scientists

Bing-Zhong Wang

Bing-Zhong Wang

University of Electronic Science and Technology of China

Michael J. Hudson

Michael J. Hudson

University of Reading

Ana Fernández-Jiménez

Ana Fernández-Jiménez

Spanish National Research Council

William L. Warren

William L. Warren

Sanofi Pasteur

Gerald Lucovsky

Gerald Lucovsky

North Carolina State University

Lorraine Maltby

Lorraine Maltby

University of Sheffield

Boaz Yuval

Boaz Yuval

Hebrew University of Jerusalem

Charles M. Epstein

Charles M. Epstein

Emory University

Fritz Hohagen

Fritz Hohagen

University of Lübeck

Adam Winsler

Adam Winsler

George Mason University

Omar Abdel-Wahab

Omar Abdel-Wahab

Memorial Sloan Kettering Cancer Center

Patrick Garnero

Patrick Garnero

Inserm : Institut national de la santé et de la recherche médicale

Christopher E.M. Griffiths

Christopher E.M. Griffiths

Manchester Academic Health Science Centre

Hi Yi Tsui

Hi Yi Tsui

Chinese University of Hong Kong

Donald D. Deshler

Donald D. Deshler

University of Kansas

Keiichi Umetsu

Keiichi Umetsu

Institute of Astronomy and Astrophysics, Academia Sinica

Something went wrong. Please try again later.